Will Quince, MP for Colchester and Health Minister visited Rowlands pharmacy on Friday (20 January) in Nayland Road in his constituency.
The important role played by pharmacies in providing NHS care, support, and advice helping the local community to live healthier lives and manage long-term conditions
were discussed among the pharmacy teams.
Mr Quince said: "Community pharmacy is playing an increasingly important role in ensuring people in Colchester have convenient walk-in access to the healthcare
support and advice they need.
Pharmacies are not simply places to collect prescriptions, they provide a wide range of services and are the third pillar of access to primary care alongside GPs and
A&E. I would urge people to think pharmacy first if they have a minor ailment; need advice on taking their medication; want to stop smoking or want to check their
blood pressure."
Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma.
Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General
Manager, India.
Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey.
She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling
healthcare inequalities and advancing sustainable healthcare.
Commenting on her new role, Manja said: "It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present
and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland."
As 19th September has been declared a bank holiday for Her Majesty Queen Elizabeth II's state funeral, the Pharmaceutical Services Negotiating Committee (PSNC)
has advised that there is a need for some pharmacies to remain open for public interest.
NHS England has discussed with PSNC how this will impact community pharmacy and is in the process of sending a letter to all contractors, setting out the above and
requesting that they work with their local NHS England team to help plan arrangements for pharmaceutical provision in the area on the 19th of September.
In considering arrangements for the 19th, contractors are encouraged to:
Consider the needs of their patients, including any specific clinical needs, since patients have little time to prepare. In particular, patients who collect
controlled drugs in instalments should be considered, noting the use of approved Home Office wording on prescriptions (see further information on our Controlled
Drug prescription forms webpage).
Consider staff availability. It is likely that many schools and childcare settings will close, affecting childcare arrangements.
Boots UK will offer a staring salary of £42,000 per annum to newly qualified pharmacists joining the pharmacy chain.
The company also revealed that "in addition, any existing pharmacists in the bargaining unit currently receiving less than £43k."
The newly announced hike in the salary - following an agreement reached between the multiple and and the Pharmacist Defence Association - will be effective from
1 August 2022.
"This enhanced offer for Newly Qualified Pharmacists and further investment in those in the early stages of their careers at Boots is a key part of our commitments
to pharmacists," the company said.
Boots and PDA Union also announced in a joint statement that they will conduct a further formal review of all pharmacists' pay in accordance with the collective
agreement, effective from 1 November 2022.
Boots has become the first community pharmacy in the UK to transport prescription medicines by a drone.
The pharmacy multiple completed a test flight transporting prescription-only medicines by drone from Portsmouth to the Isle of Wight earlier this month.
The flight departed from the British Army's Baker Barracks on Thorney Island near Portsmouth and arrived at St. Mary's Hospital on the Isle of Wight. The medicines
were collected by Boots personnel and transported to the multiple's pharmacies across the island, where they will be dispensed to patients with prescriptions for them.
Boots worked with medical drone start-up Apian to facilitate the test flight and is now assessing the future potential for drones in medicines delivery.
Rich Corbridge, chief information officer at Boots, said: "Drones have a huge potential in the delivery of medicines and it is incredibly exciting to be the first
community pharmacy in the UK to transport them in this way. An island location like the Isle of Wight seemed like a sensible place to start a trial of drones and
their value to the delivery of medicines to more remote locations is very clear.
The Pharmacists' Defence Association's anti-racist pharmacy toolkit was launched at the 2022 Clinical Pharmacy Congress.
The event also included a demonstration of how members could use the toolkit to work together to address inequality and discrimination in their workplace.
Elsy Gomez Campos, president of the PDA BAME Pharmacists' Network, gave an overview of issues raised by network members as well as broader professional issues
including over-representation of BAME pharmacists in fitness to practice complaints, under-representation of BAME pharmacists in leadership roles, limited access
to post-graduate education, and bullying and discrimination in the workplace.
She concluded her opening statement by reminding members of what an exemplary pharmacy profession should look like which is about "being treated fairly and being
offered the same opportunities to those that do not look like us."
Manuella Asso, organising assistant and PDA BAME Pharmacists' Network coordinator, explained that the toolkit for was representatives, members, and other pharmacists
to assess their workplaces and to help them take collective action to create an anti-racist workplace culture and environment.
An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights
for Covid-19 interventions between the pharmaceutical industry and developing nations endures.
At the heart of the plan is a commitment to set aside part of the production of vaccines and treatments upfront for vulnerable populations in low-income countries
when the next pandemic arises, given how fragmented access to Covid tools has left many populations unprotected.
In order to do better next time - and without knowing which companies will develop the first drugs and vaccines for the next pandemic - having the industry
collectively make this commitment is potentially transformative, said Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers &
Associations (IFPMA).
The pledge, called the Berlin Declaration, was made on July 19 by members of the global pharmaceutical industry group that include many of the companies involved
in developing Covid interventions, such as AstraZeneca, GSK, Moderna, Pfizer and Merck.
The declaration is not legally binding.
However, if a company that signed on reneges on its vow, it would face grave consequences in the court of public opinion, said Cueni.
IAM Healthcare and pharmacy labour activists have initiated a new worker empowerment project to help pharmacies unionise over unsafe staffing levels and
increasing workloads.
The campaign is coined "The Pharmacy Guild" to establish higher standards of practice in pharmacies to protect patients.
The union issued a mission statement on Wednesday (8 November) highlighting three major demands and goals.
They demanded that "staffing and workload standards should be set up to ensure safe patient care."
There should be "representation and collective bargaining for pharmacy professionals in workplaces across the country."
The International Pharmaceutical Federation (FIP) launched a report on pharmacy-led common ailment schemes.
The data was collected from 24 countries, including case studies from nine countries.
It highlighted the growing demand for care models for ageing populations and the increase in chronic non-communicable diseases.
Pharmacists had been managing the stress, including prescribing authority and provision of medicinal treatments.
Paul Sinclair AM, Global President of FIP, said, "I believe this report is both a foundation and a catalyst - a foundation on which FIP and our member
organizations could base initial strategies and a catalyst to drive us to seek even more diverse and comprehensive insights in the future.
The Scottish government is planning to publish its review report on use of automated technology in community pharmacies by the end of 2023.
The technology being trialled as part of the pilot includes robotic process automation, automated medicine storage systems, barcode scanners and prescription
collection kiosks.
The evaluation, which started prior to the COVID-19 pandemic, is due to be completed at the end of November 2023.
Patricia Findlay, professor of work and employment relations at the University of Strathclyde, who was commissioned to produce the report, told The
Pharmaceutical Journal that the pilot pharmacies taking part in the scheme are all based in Scotland, but she didn't reveal their names.
People are advised to be prepared and order their repeat prescriptions in time so that they don't run out of their routine medicines over the Christmas and
New Year break when services are likely to be busier than normal.
As GP practices will be closed over the bank holidays and only some pharmacies will remain open, local NHS leaders have urged patients to plan ahead to avoid making
last-minute requests for collecting repeat prescriptions, which can add avoidable pressure for doctors, pharmacies, and other NHS services.
Sati Ubhi, Chief Pharmacist at NHS Cambridgeshire & Peterborough, have cautioned patients that running out of their usual medication can have serious consequences.
"By ordering medicines as soon as possible, it allows enough time for it to be processed and dispensed and helps avoid a last-minute rush," she told Fenland Citizen.
The Pharmacists' Defence Association (PDA) has reiterated its call for all pharmacists working at Boots to join the PDA Union to support the collective voice of the profession within the company.
It said this would enable PDA to send direct communications to pharmacists working at Boots and keep them up to date with key matters impacting their work life.
Currently, the association uses the company communication channels to cascade key information to the non-member pharmacists, however, it fears such measures can be
disrupted by management.
Besides, having more member pharmacists at Boots would strengthen their "negotiating power", PDA said.
Health and Social Care Secretary Sajid Javid and Madelaine McTernan, head of the HRT supply taskforce, continue to take urgent action to resolve the shortage of HRT medicines by meeting the drug manufacturers and representatives from community pharmacies on Thursday (May 5).
In the meeting, manufacturers outlined the steps they're taking to boost supply, and pharmacists shared their experiences on the frontline, as well as sharing their
thoughts on wider solutions including improved communications.
Aspen Pharmacare, Besins-Healthcare, Gedeon Richter, Novartis, Novo Nordisk, Orion, Pfizer, Theramex, Viatris, and representatives from community pharmacies were
part of the meeting.
As the government confirmed its intention to work with industry to do what is necessary to fix the HRT supply issue, Javis said he wanted to understand the issues
facing suppliers and what can be done to address them.
"We will leave no stone unturned in our national mission to boost supply of HRT. Along with appointing Madelaine McTernan as head of the HRT supply taskforce to implement lessons learned from the pandemic, and ensuring prescriptions are issued in shorter cycles for now, we are working collectively with the sector to urgently resolve this issue," he commented.
The Association of Independent Multiple Pharmacies (AIMp) said the meeting discussed 'why we got into this position' and the way forward.
Numark is set to launch a large-scale broadcast campaign to promote its Hey Pharmacist repeat prescription service on May 22.
The new campaign introduces, 'Repeat prescriptions. Made simple,' with a set of three TV adverts that feature three different heightened-reality scenarios. In
each advert, the hero discovers they have forgotten to order their repeat prescription at a less than ideal time but thanks to Hey Pharmacist, a few taps later
their problems are solved.
The adverts highlight how managing your repeat prescriptions has never been quicker or simpler in a tongue-in-cheek, comedic tone.
The campaign - which incorporates national broadcast and SkyAdSmart TV alongside digital, social, and in-store campaigns across England - promotes the Hey Pharmacist
app which provides Numark members in England with an end-to-end online repeat prescription proposition, helping them deliver a best-in-class digital capability which
highlights the benefits for patients who choose to collect their medication from their local Numark pharmacy.
Jeremy Meader, managing director of Numark, commented: "It is very exciting to see our first TV campaign go live. The creative does a brilliant job in bringing to life the benefits of Hey Pharmacist, highlighting how easy and effortless managing
prescriptions can be. We look forward to assisting more everyday heroes and supporting our members in showcasing this exciting digital proposition to a larger audience."
The UK Health Security Agency (UKHSA) has said that monkeypox is to be listed as a notifiable disease in law from Wednesday (June 8).
The new legislation means all doctors in England are required to notify their local council or local Health Protection Team (HPT) if they suspect a patient has monkeypox. Laboratories must also notify the UKHSA if the monkeypox virus is identified in a laboratory sample.
Wendi Shepherd, monkeypox incident director at UKHSA, said: "Rapid diagnosis and reporting is the key to interrupting transmission and containing any further spread of monkeypox. This new legislation will support us and our health partners to swiftly identify, treat and control the disease.
"It also supports us with the swift collection and analysis of data which enables us to detect possible outbreaks of the disease and trace close contacts rapidly, whilst offering vaccinations where appropriate to limit onward transmission."
The Department of Health and Social Care (DHSC) launched a new Innovative Medicines Fund on Tuesday (June 7) under which £340 million has been made available
to purchase potentially life-saving drugs early.
This will allow NHS patients in England to have early access to potentially life-saving and cutting-edge treatments
Health secretary Sajid Javid said: "I want NHS patients to be the first in the world to access the most promising and revolutionary treatments that could extend or
save their lives.
"The launch of the Innovative Medicines Fund delivers another manifesto pledge and will fast-track cutting-edge medicines to adults and children to give people
renewed hope for a better future."
A total of £680 million has been ringfenced for the Innovative Medicines Fund and Cancer Drugs Fund - £340 million each - to fast-track medicines to NHS patients.
DHSC said: "The Innovative Medicines Fund will provide quick access to novel treatments, including potentially lifesaving gene therapies for serious conditions with
few treatment options. It often takes longer for pharmaceutical companies to collect data on a medicine's clinical and cost effectiveness for rare diseases due to
the smaller patient cohort.
The result from the Royal Pharmaceutical Society (RPS)'s survey showed that pharmacists witnessed 'the cost of living is having an impact on whether people
can afford prescription medicines in England'.
RPS has long campaigned to remove prescription charges for people with long-term conditions in England because they create a financial barrier to patients receiving
the medicines needed to keep them well.
The charge currently stands at £9.35 per item prescrib9ed and an annual rise usually occurs in April. Prescriptions are free for people in Scotland, Wales and
Northern Ireland.
One in two pharmacists who responded to the survey said they've seen an increase in the last six months in patients asking them which medicines on their prescription
they can 'do without' due to affordability issues.
One in two pharmacists had seen a rise in people not collecting their prescription, whilst two out of three pharmacists reported an increase in being asked if there
was a cheaper, over-the-counter substitute for the medicine they had been prescribed.
Proper drug storage is essential to ensure the safety of yourself, your family, and those around you. This is especially important if you are taking multiple
medications and need to keep track of them all. Knowing how to store drugs correctly can help prevent misuse or accidental ingestion by children or pets. Here are
six important guidelines about proper drug storage that everyone should follow:
1. KEEP ALL MEDICATIONS IN THEIR ORIGINAL, LABELED CONTAINERS:
Using alternative storage containers can make it difficult to identify medications or keep track of expiration dates. Keeping medications in their original containers
also prevents accidental misuse and helps ensure that the correct dosage is taken. In addition, it's important to store all medications out of reach of children and
pets. Also, keep medications in a cool, dry place away from direct sunlight. For example, a medicine cabinet in the bathroom or kitchen is a good option.
2. DISPOSE OF EXPIRED MEDICATIONS:
Expired medications can be less effective and even potentially harmful if taken, so it's important to regularly check expiration dates and get rid of any outdated
medications. The best way to dispose of old drugs is to take them to a drug collection site. If no such sites are available, mix the medication with something like
coffee grounds, put it in an opaque container, and then throw it away in your trash bin. Never flush expired medication down the toilet unless instructed by your
pharmacist or healthcare provider!
3. STORE DRUGS IN A COOL, DRY PLACE:
Extreme temperatures can cause medications to break down and become ineffective. To avoid this, keep all drugs away from direct sunlight, heat sources, and moisture.
A medicine cabinet or drawer in the bathroom is an ideal spot for storing most drugs, but some require special storage conditions (more on that below). Different
medications should also be separated from one another to avoid confusion and stored differently. For example, if a
The Serious Shortage Protocol (SSP), for Estradot 50mcg patches will expire at 23.59pm on Friday 24 February 2023.
Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot 50mcg patches are now available to meet normal demand.
"After 24th February, any prescriptions for Estradot 50mcg patches must be dispensed in accordance with the prescription, and SSP048 will no longer be valid for
use," said DHSC.
Top tips for SSP claims by PSNC:
Where available, use the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month.
For any supplies made in accordance with SSPs, check that the correct number of patient charges are collected and declared on the end of month FP34C submission.
NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous - NHSBSA
processing staff must be able to determine what has been supplied. NHSBSA have published information on common SSP endorsing errors they see when processing claims.
The Department of Health and Social Care (DHSC) has announced 30 pence increase in prescription charges from £9.35 to £9.65 for each medicine or appliance
dispensed.
Board Chair for England at RPS, Thorrun Govind commented: "This is a kick in the teeth for people in England who are already struggling with rising bills and food
prices.
"Patients groups have warned that people are not collecting prescription medicines due to cost and pharmacists are seeing this worrying trend first-hand.
"A Government impact assessment noted the risk of adverse effects of people not taking their medicines, resulting in future health problems for the individual,
potential hospital admissions, and a subsequent cost to the NHS.
"This decision seems to prioritise revenue generation over ill-health prevention and undermines the principle of an NHS free at the point of use.